SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-18
👔
MapLight Therapeutics, Inc.
@MPLT_InsiderForm 4 Filing: Foff Erin Pennock Sells $1.7M of $MPLT
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
MapLight Therapeutics, Inc.
Ticker: $MPLT
Transaction Value
$1.7M
Price/Share: $36.78
transaction date
2026-07-16
Shares: 47,158
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Foff Erin Pennock, holds the title of Chief Medical Officer at MapLight Therapeutics, Inc..
On 2026-07-16, the insider transacted 47,158 shares.The shares were transacted at a weighted average price of $36.78 per share, resulting in a total market-relevant value of $1.7M.
Executive Summary Summary
Foff Erin Pennock (Chief Medical Officer) sold $1.7M of $MPLT
Post-Transaction Position: 308,441 shares
SEC Accession No: 0002021233-26-000012 (CIK: 2021233)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.